These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17964916)

  • 61. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.
    Miller AE; Hansen LB; Saseen JJ
    Pharmacotherapy; 2008 May; 28(5):553-61. PubMed ID: 18447653
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 63. At which stage of chronic kidney disease should dyslipidemia be treated?
    Krane V; Wanner C
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):176-7. PubMed ID: 16932418
    [No Abstract]   [Full Text] [Related]  

  • 64. Diabetic dyslipidemia: a practical guide to therapy.
    Tovar JM; Bazaldua OV; Loffredo A
    J Fam Pract; 2008 Jun; 57(6):377-88. PubMed ID: 18544321
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Psoriasis and serum lipid abnormalities.
    Pietrzak A; Chodorowska G; Szepietowski J; Zalewska-Janowska A; Krasowska D; Hercogová J
    Dermatol Ther; 2010; 23(2):160-73. PubMed ID: 20415824
    [No Abstract]   [Full Text] [Related]  

  • 66. A call for development of comprehensive therapy for dyslipidemia.
    Deshpande NV; Mardikar HM; Deo D
    J Am Coll Cardiol; 2007 Apr; 49(13):1502; author reply 1502-3. PubMed ID: 17397683
    [No Abstract]   [Full Text] [Related]  

  • 67. Will obesity increase the proportion of children and adolescents recommended for a statin?
    McCrindle BW; Tyrrell PN; Kavey RE
    Circulation; 2013 Nov; 128(19):2162-5. PubMed ID: 24190936
    [No Abstract]   [Full Text] [Related]  

  • 68. Summary of the American Heart Association's scientific statement on drug therapy of high-risk lipid abnormalities in children and adolescents.
    McCrindle BW; ; Urbina EM; Dennison BA; Jacobson MS; Steinberger J; Rocchini AP; Hayman LL; Daniels SR
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):982-5. PubMed ID: 17442893
    [No Abstract]   [Full Text] [Related]  

  • 69. Rate of Statin Prescription in Younger Patients With Severe Dyslipidemia.
    Al-Kindi SG; DeCicco A; Longenecker CT; Dalton J; Simon DI; Zidar DA
    JAMA Cardiol; 2017 Apr; 2(4):451-452. PubMed ID: 28052161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glucocorticoids and cardiovascular risk factors.
    Strohmayer EA; Krakoff LR
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):409-17, ix. PubMed ID: 21565675
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cholesterol and peripheral vascular disease: a neglected topic?
    Atar D; Jørgensen JJ
    Scand Cardiovasc J; 2007 Jun; 41(3):136-7. PubMed ID: 17487760
    [No Abstract]   [Full Text] [Related]  

  • 72. [Lipid metabolism diseases].
    Schwandt P
    Med Monatsschr Pharm; 2003 Nov; 26(11):368-72; quiz 373-4. PubMed ID: 14652921
    [No Abstract]   [Full Text] [Related]  

  • 73. [Thrombocyte-vascular and sero-coagulation hemostasis, and blood lipids in the acute period of ischemic stroke].
    Iasamanova AN; Martynov MIu; Sudmol NN
    Klin Med (Mosk); 2005; 83(11):26-9. PubMed ID: 16404935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lipoprotein metabolism and lipid management in chronic kidney disease.
    Kwan BC; Kronenberg F; Beddhu S; Cheung AK
    J Am Soc Nephrol; 2007 Apr; 18(4):1246-61. PubMed ID: 17360943
    [No Abstract]   [Full Text] [Related]  

  • 75. MY APPROACH to the Patient With Memory Loss Who Needs a Statin.
    Watson KE; Sallam T
    Trends Cardiovasc Med; 2017 Feb; 27(2):158-159. PubMed ID: 28107839
    [No Abstract]   [Full Text] [Related]  

  • 76. Treating hypertriglyceridemia.
    Yavasoglu I; Kadikoylu G; Bolaman Z
    CMAJ; 2007 Sep; 177(6):603-4; author reply 604-5. PubMed ID: 17846443
    [No Abstract]   [Full Text] [Related]  

  • 77. Treating dyslipidemia of the metabolic syndrome: where's the evidence?
    Eckel RH
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):437. PubMed ID: 17515887
    [No Abstract]   [Full Text] [Related]  

  • 78. Dyslipidemia in renal disease: causes, consequences and treatment.
    Mesquita J; Varela A; Medina JL
    Endocrinol Nutr; 2010 Nov; 57(9):440-8. PubMed ID: 20850395
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Update on lipids and C-reactive protein in acute and chronic coronary heart disease.
    Jones PH
    Tex Heart Inst J; 2010; 37(3):307-8. PubMed ID: 20548807
    [No Abstract]   [Full Text] [Related]  

  • 80. Insulin resistance, dyslipidemia, and cardiovascular disease.
    Bloomgarden ZT
    Diabetes Care; 2007 Aug; 30(8):2164-70. PubMed ID: 17855278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.